Congrès de l’ESHRE : 1-4 juillet 2012 à Istanbul

The European Society of Human Reproduction and Embryology bridges East and West for its 2012 Congress in Istanbul. The European Society of Human Reproduction and Embryology (ESHRE) announced today that it has chosen Istanbul for its 2012 Annual Meeting. During 1 to 4 July 2012, ESHRE will hold its Annual Meeting at the Istanbul Congress Centre (ICC). Reproductive medicine is one of today’s most exciting scientific and clinical areas. Every month there are announcements of medical ‘firsts’, new rulings by regulatory bodies or ethical controversies. These often spark a heated debate among practitioners in the field, ethicists, legislators, the media and the public. ESHRE’s Annual Meeting is the forum where more than 9,000 of the world’s leading experts in reproductive medicine gather to give a public presentation of their latest research findings.

“The ESHRE Annual Meeting is a great opportunity to discuss progress and the latest breakthroughs in reproductive medicine. This event addresses current and emerging health science, policy and practice issues in the field. Many of the participants come to hear about cutting edge research,” says Dr. Luca Gianaroli, current ESHRE chairman. “Nothing illustrates the achievements of reproductive medicine more than the fact that in some European countries up to 5% of children are born using assisted reproduction technologies. With an ever-so-fast changing field, our Annual Congress is the world’s premier reproductive science conference.”

Topic categories:

• Basic science
• Clinical science
• Mixed (basic/clinical)
• Paramedical (ie nurses, lab. technicians & allied personnel)


when Basic science, Clinical science or Mixed (Basic/Clinical) are selected:

• Cross border reproductive care
• Developing countries and infertility
• Early pregnancy (incl. miscarriage, recurrent miscarriages, abortion, termination of pregnancy, ectopic pregnancy, molar pregnancy)
• Embryology (incl. IVF/ICSI, gamete and embryo selection, culture, cryopreservation, vitrification, developmental biology)
• Endometriosis, endometrium, implantation and fallopian tube
• Ethics and law
• Female (in)fertility (incl. oogenesis, diagnostic tests, prognostic models, intrauterine insemination, oocyte donation, body weight effects, smoking, ageing, immunology,sexually transmitted diseases)
• Andrology / (incl. male (in)fertility, spermatogenesis, diagnostic tests, treatment, MESA, TESA, TESE, sperm donation, environmental factors related to male fertility, immunology)
• Male and female contraception
• Male and female fertility preservation (incl. oncofertility, medical indications, social freezing, laboratory techniques)
• Psychology and counselling
• Quality and safety of ART therapies (incl. guidelines, accreditation, EUTCD, certification, complications: premature labour, malformations, neonatal risks, multiple pregnancy, long term follow-up of children)
• Reproductive (epi)genetics (incl. (epi)genetic causes of infertility, PGD, PGS, prenatal diagnosis)
• Reproductive endocrinology (incl. ovarian reserve testing, ovarian stimulation, IVM, POF, PCOS, infancy, disorders of sexual development, puberty, adolescence, menopause )
• Reproductive epidemiology and health economy
• Reproductive surgery (female and male)
• Stem cells
• Translational research (incl. new ideas, hypotheses, new thinking, immediate applicability in practice)

when Paramedical is selected:

• Paramedical – laboratory
• Paramedical – nursing

Sources : 1 et 2